Recomendações de boas práticas de Enfermagem para Instilação Intravesical no Cancro da Bexiga: Adaptação para o Cuidado Oncológico Português
DOI:
https://doi.org/10.31877/on.2025.51.03Palavras-chave:
Administração , Intravesical, Bacillus Calmette–Guérin, Prática Baseada na Evidência, Mitomicina, Enfermagem OncológicaResumo
O estudo teve como objetivo traduzir e adaptar as recomendações de boas práticas para a instilação intravesical de terapêutica antineoplásica da Associação Europeia de Enfermeiros de Urologia para o contexto oncológico português. Foi utilizada metodologia ADAPTE (preparação, adaptação e finalização) incluindo revisão externa pelo método Delphi.
A tradução e adaptação cultural resultaram na padronização terminológica e exclusão de elementos não alinhados com o contexto nacional. As recomendações que não alcançaram consenso dentro do grupo de trabalho (n=16) foram avaliadas externamente por enfermeiros peritos em terapia antineoplásica intravesical de vários contextos oncológicos identificados por amostragem intencional e em bola de neve (n=19 Fase I, n=16 Fase II). Quatro recomendações iniciais não alcançaram consenso; duas foram eliminados e os demais foram avaliados em segunda fase.
Este estudo adaptou as recomendações ao contexto português, promovendo práticas baseadas em evidências. A sua validação confirma a relevância e aplicabilidade, fortalecendo os cuidados oncológicos em Portugal.
Downloads
Referências
1. Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer Journal for Clinicians. 2024;74(3):229-63.
2. Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, et al. Global cancer observatory: cancer today (version 1.1). Lyon, France: International Agency for Research on Cancer. 2024.
3. Liu G, Li B, Xu Z, Wang J, Ma S, Kan Y, et al. Bacillus calmette-guerin for the treatment of non-muscle invasive bladder cancer: history and current status. Discovery Medicine. 2022;33(169):85-92.
4. Witjes JA, Bruins HM, Cathomas R, Compérat EM, Cowan NC, Gakis G, et al. European Association of Urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines. European Urology. 2021;79(1):82-104.
5. Lobo N, Brooks NA, Zlotta AR, Cirillo JD, Boorjian S, Black PC, et al. 100 years of Bacillus Calmette–Guérin immunotherapy: from cattle to COVID-19. Nature Reviews Urology. 2021;18(10):611-22.
6. Duan H, Deng Z, Zou J, Zhang G, Zou X, Xie T. The Efficacy and Safety of Hyperthermia Intravesical Chemotherapy in the Treatment of Non-Muscle-Invasive Bladder Cancer: A Meta-Analysis. Urologia Internationalis. 2024;108(4):322-33.
7. Li R, Li Y, Song J, Gao K, Chen K, Yang X, et al. Intravesical gemcitabine versus mitomycin for non-muscle invasive bladder cancer: a systematic review and meta-analysis of randomized controlled trial. BMC Urology. 2020;20:1-8.
8. Burroughs GE, Connor TH, Mead KR, Reed LD. Preventing occupational exposure to antineoplastic and other hazardous drugs in health care settings. CA Cancer Journal for Clinicians. 2006;56(6):354-65.
9. Lauridsen SV, De Blok W, Retinger NL, Jensen BT, Turner B, Villa G, et al. Intravesical instillation with mitomycin C or bacillus Calmette-Guérin in non-muscle invasive bladder cancer: European Association of Urology Nursing; 2015.
10. Keeney S, Hasson F, McKenna H. Consulting the oracle: ten lessons from using the Delphi technique in nursing research. Journal of Advanced Nursing. 2006;53(2):205-12.
11. Benner P. From novice to expert: Excellence and power in clinical nursing practice. Commemorative edition: Prentice-Hall International London; 2001.
12. Portuguese Nursing Order Parecer n.º 10/2017: Diferenciação das intervenções de enfermagem do enfermeiro especialista em enfermagem médico-cirúrgica em relação ao enfermeiro generalista, num serviço de urgência. 2017.
13. Kennedy HP. Enhancing Delphi research: methods and results. Journal of Advanced Nursing. 2004;45(5):504-11.
14. Gisev N, Bell JS, Chen TF. Interrater agreement and interrater reliability: key concepts, approaches, and applications. Research in Social and Administrative Pharmacy. 2013;9(3):330-8.
15. Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. Journal of Chiropractic Medicine. 2016;15(2):155-63.
16. European Commission. Guidance for the Safe Management of Hazardous Medicinal Products at Work. 2023.
17. Peyton CC, Chipollini J, Azizi M, Kamat AM, Gilbert SM, Spiess PE. Updates on the use of intravesical therapies for non-muscle invasive bladder cancer: how, when and what. World Journal of Urology. 2019;37:2017-29.
18. Szewczyk Jr MT, Soefje SA. Development of an innovative delivery system for bacillus Calmette-Guérin bladder administration. American Journal of Health-System Pharmacy. 2021;78(1):60-4.
19. Marx AH, Nowicki DN, Carlson RB, Schultz KM, Sickbert-Bennett E, Weber DJ. Bacille Calmette-Guérin preparation and intravesical administration to patients with bladder cancer: risks to healthcare personnel and patients, and mitigation strategies. Infection Control & Hospital Epidemiology. 2024;45(4):520-5.
20. Liu S, Zhang C, Peng L, Lu Y, Luo D. Comparative effectiveness and safety of intravesical instillation treatment of interstitial cystitis/bladder pain syndrome: a systematic review and network meta-analysis of randomized controlled trials. International Urogynecology Journal. 2021;32:1061-71.
21. Simons A, Toland S. Protecting nurses against the risks of occupational exposure to systemic anticancer therapy agents. Cancer Nursing Practice. 2024;23(4).
22. Connor TH, McDiarmid MA. Preventing occupational exposures to antineoplastic drugs in health care settings. CA Cancer Journal for Clinicians. 2006;56(6):354-65.
23. Wang T, Tan J-YB, Liu X-L, Zhao I. Barriers and enablers to implementing clinical practice guidelines in primary care: an overview of systematic reviews. BMJ open. 2023;13(1):e062158.
24. Wang Z, Norris SL, Bero L. The advantages and limitations of guideline adaptation frameworks. Implementation Science. 2018;13:1-13.
25. Klaic M, Kapp S, Hudson P, Chapman W, Denehy L, Story D, et al. Implementability of healthcare interventions: an overview of reviews and development of a conceptual framework. Implementation Science. 2022;17(1):10.
26. Bora A-M, Piechotta V, Kreuzberger N, Monsef I, Wender A, Follmann M, et al. The effectiveness of clinical guideline implementation strategies in oncology—a systematic review. BMC Health Services Research. 2023;23(1):347.
Downloads
Publicado
Como Citar
Edição
Secção
Licença
Direitos de Autor (c) 2025 Filipa Ventura, Vânia Maria Azevedo Ribeiro, Inês Gonçalves Vicente Claro, Armando Luís Teixeira dos Santos Silva, Ana Rita Águas Afonso Silva, Susana Cláudia Fernandes Gonçalves Marques, Maria Cecília Magalhães Girão, Cristina Maria Oliveira Santos, Raquel Chemela, Maria Esmeralda Reis Barreira
Este trabalho encontra-se publicado com a Licença Internacional Creative Commons Atribuição 4.0.
